Congenital heart disease and pulmonary hypertension (cardiology for pulmonologists)

M. D'Alto (Naples, Italy)

Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Number: 14
Disease area: Pulmonary vascular diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. D'Alto (Naples, Italy). Congenital heart disease and pulmonary hypertension (cardiology for pulmonologists). ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
Source: Eur Respir Rev 2009; 18: 154-161
Year: 2009



Pulmonary arterial hypertension: a comparison between children and adults
Source: Eur Respir J 2011; 37: 665-677
Year: 2011



Changing demographics of pulmonary arterial hypertension in congenital heart disease
Source: Eur Respir Rev 2010 19: 308-313
Year: 2010



Pulmonary hypertension associated with congenital heart disease (PH-CHD): Results from the ASPIRE registry
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Hemodynamic assessment of pulmonary hypertension in corrected versus non-corrected grown-up congenital heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD)
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019



Initial experience of sildenafil in patients with congenital heart disease (CHD) associated pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2006; 28: Suppl. 50, 425s
Year: 2006

Adult congenital heart disease and pulmonary hypertension: management of a complex case
Source: Eur Respir Rev 2012 21: 362-364
Year: 2012


Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003



Nebulised Iloprost for pulmonary arterial hypertension associated with congenital heart disease: one centre's experience
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001

Characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease in the French PAH registry
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011


Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012


Managing pulmonary hypertension in patients with congenital heart disease
Source: Eur Respir Mon 2012; 57: 71-81
Year: 2012


Pulmonary hypertension due to left heart disease
Source: Eur Respir J, 53 (1) 1801897; 10.1183/13993003.01897-2018
Year: 2019



Pulmonary hypertension in left heart, respiratory and trombo-embolic pulmonary disease
Source: International Congress 2015 – Pulmonary hypertension
Year: 2015



Interdisciplinary rehabilitation in pulmonary hypertension: can we learn from chronic obstructive pulmonary disease or heart failure?
Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure
Year: 2018


Hemodynamic assessment of pulmonary hypertension in grown-up congenital heart disease
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012

Bosentan treatment for pulmonary arterial hypertension related to congenital heart disease: real-world clinical experience in Spain
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009